Global Emergency Contraceptives Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Emergency Contraceptives Market Insights, Forecast to 2034
The emergency contraceptives market refers to the industry involved in the production, distribution, and sale of medications and products used for emergency contraception. Emergency contraceptives, also known as "morning-after pills," are designed to prevent pregnancy after unprotected intercourse or contraceptive failure.
Global Emergency Contraceptives market is expected to reach to US$ 611 million in 2024, with a positive growth of %, compared with US$ 568 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Emergency Contraceptives industry is evaluated to reach US$ 936.7 million in 2029. The CAGR will be 7.4% during 2024 to 2029.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.
Report Covers
This report presents an overview of global Emergency Contraceptives market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Emergency Contraceptives market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
Segment by Type
Combined Estrogen and Progestin Pills
Progestin-Only (As Levonorgestrel) Pills
Antiprogestin (As Mifepristone) Pills
Ulipristal Acetate Pills
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Emergency Contraceptives plant distribution, commercial date of Emergency Contraceptives, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Emergency Contraceptives introduction, etc. Emergency Contraceptives Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Emergency Contraceptives
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Emergency Contraceptives market is expected to reach to US$ 611 million in 2024, with a positive growth of %, compared with US$ 568 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Emergency Contraceptives industry is evaluated to reach US$ 936.7 million in 2029. The CAGR will be 7.4% during 2024 to 2029.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.
Report Covers
This report presents an overview of global Emergency Contraceptives market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Emergency Contraceptives market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
Segment by Type
Combined Estrogen and Progestin Pills
Progestin-Only (As Levonorgestrel) Pills
Antiprogestin (As Mifepristone) Pills
Ulipristal Acetate Pills
Segment by Application
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Emergency Contraceptives plant distribution, commercial date of Emergency Contraceptives, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Emergency Contraceptives introduction, etc. Emergency Contraceptives Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Emergency Contraceptives
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports